Systems biology-based diagnostic principles as pillars of the bridge between Chinese and Western medicine.

Innovative systems approaches to develop medicine and health care are emerging from the integration of Chinese and Western medicine strategies, philosophies and practices. The two medical systems are highly complementary as the reductionist aspects of Western medicine are favourable in acute disease situations and the holistic aspects of Chinese medicine offer more opportunities in chronic conditions and for prevention. In this article we argue that diagnosis plays a key role in building the bridge between Chinese and Western medicine. Recent advances in the study of health, healing, placebo effects and patient-physician interactions will be discussed pointing out the development of a system-based diagnosis. Especially, a system biology-based diagnosis can be used to capture phenotype information, leading towards a scientific basis for a more refined patient characterization, new diagnostic tools and personalized heath strategies. Subtyping of rheumatoid arthritis patients based on Chinese diagnostic principles is discussed as an example. New insights from this process of integrating Western and Chinese medicine will pave the way for a patient-centred health care ecosystem.

[1]  Sonali Patil,et al.  Getting Started in Biological Pathway Construction and Analysis , 2008, PLoS Comput. Biol..

[2]  Satoru Kawai,et al.  An Algorithm for Drawing General Undirected Graphs , 1989, Inf. Process. Lett..

[3]  J. Smolen,et al.  Challenges of predicting treatment response in patients with rheumatoid arthritis , 2005, Nature Clinical Practice Rheumatology.

[4]  G. Lewith,et al.  Circular instead of hierarchical: methodological principles for the evaluation of complex interventions , 2006 .

[5]  Barker Bausell,et al.  Variability in the traditional Chinese medicine (TCM) diagnoses and herbal prescriptions provided by three TCM practitioners for 40 patients with rheumatoid arthritis. , 2005, Journal of alternative and complementary medicine.

[6]  T. Huizinga,et al.  Emerging patterns of risk factor make-up enable subclassification of rheumatoid arthritis. , 2007, Arthritis and rheumatism.

[7]  I. Kirsch,et al.  Listening to Prozac but Hearing Placebo: A Meta-Analysis of Antidepressant Medication , 1998 .

[8]  R. Straub,et al.  Neuroendocrine immune pathways in chronic arthritis. , 2008, Best practice & research. Clinical rheumatology.

[9]  F. Benedetti,et al.  Electrophysiological properties of thalamic, subthalamic and nigral neurons during the anti‐parkinsonian placebo response , 2009, The Journal of physiology.

[10]  Fabrizio Benedetti,et al.  New Insights into the Placebo and Nocebo Responses , 2008, Neuron.

[11]  J. Lovelock,et al.  Atmospheric homeostasis by and for the biosphere: the gaia hypothesis , 1974 .

[12]  W. Jonas,et al.  Placebo research: the evidence base for harnessing self-healing capacities. , 2004, Journal of alternative and complementary medicine.

[13]  Cheng Lu,et al.  Correlations Between Symptoms as Assessed in Traditional Chinese Medicine (TCM) and ACR20 Efficacy Response: A Comparison Study in 396 Patients With Rheumatoid Arthritis Treated With TCM or Western Medicine , 2007, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

[14]  D. Symmons Epidemiology of rheumatoid arthritis: determinants of onset, persistence and outcome. , 2002, Best practice & research. Clinical rheumatology.

[15]  Thomas Hankemeier,et al.  Effects of growth conditions and processing on Rehmannia glutinosa using fingerprint strategy. , 2006, Planta medica.

[16]  Bengt Lindström,et al.  Salutogenesis , 2005, Journal of Epidemiology and Community Health.

[17]  Claudia Mauri,et al.  Cells of the synovium in rheumatoid arthritis , 2007 .

[18]  Jan van der Greef,et al.  Quality and safety of Chinese herbal medicines guided by a systems biology perspective. , 2009, Journal of ethnopharmacology.

[19]  C. Otto Scharmer,et al.  Theory U: Leading from the Future as it Emerges , 2007 .

[20]  K. Moudgil,et al.  Celastrus aculeatus Merr. suppresses the induction and progression of autoimmune arthritis by modulating immune response to heat-shock protein 65 , 2007, Arthritis research & therapy.

[21]  J J Anderson,et al.  Factors predicting response to treatment in rheumatoid arthritis: the importance of disease duration. , 2000, Arthritis and rheumatism.

[22]  D. Fox,et al.  Cells of the synovium in rheumatoid arthritis , 2007 .

[23]  Harald Walach,et al.  The therapeutic effect of clinical trials: understanding placebo response rates in clinical trials – A secondary analysis , 2005, BMC medical research methodology.

[24]  Matej Oresic,et al.  Integrative biological analysis of the APOE*3-leiden transgenic mouse. , 2004, Omics : a journal of integrative biology.

[25]  G. Moddeman,et al.  Unraveling the Mystery of Health , 1995 .

[26]  Reinhard Guthke,et al.  Rheumatoid arthritis, a complex multifactorial disease: On the way toward individualized medicine , 2006, Medicinal research reviews.

[27]  A. Antonovsky Unraveling the mystery of health: how people manage stress and stay well , 1987 .

[28]  F. Benedetti Mechanisms of placebo and placebo-related effects across diseases and treatments. , 2008 .

[29]  K. Tracey,et al.  Autonomic neural regulation of immunity , 2005, Journal of internal medicine.

[30]  Sebastian Sauer,et al.  Facets of mindfulness – Results of an online study investigating the Freiburg mindfulness inventory , 2009 .

[31]  S. Banerjee,et al.  Inhibition of type II collagen induced arthritis in mice by an immunosuppressive extract of Tripterygium wilfordii Hook f. , 1992, The Journal of rheumatology.

[32]  J. van der Greef,et al.  The role of analytical sciences in medical systems biology. , 2004, Current opinion in chemical biology.

[33]  H. Tan,et al.  The effect of Chinese herbal medicines (CHM) on menopausal symptoms compared to hormone replacement therapy (HRT) and placebo. , 2007, Maturitas.

[34]  A. Gaines,et al.  Physicians of Western Medicine , 1984 .

[35]  Giovanni Maciocia,et al.  The Foundations of Chinese Medicine: A Comprehensive Text for Acupuncturists and Herbalists , 2005 .

[36]  W. Pagel Prognosis and Diagnosis: A Comparison of Ancient and Modern Medicine , 1939, Journal of the Warburg Institute.

[37]  Wayne B Jonas,et al.  Deconstructing the Placebo Effect and Finding the Meaning Response , 2002, Annals of Internal Medicine.

[38]  Khalil M. Dirani Theory U: Leading from the Future as it Emerges , 2011 .

[39]  Blair T. Johnson,et al.  Initial Severity and Antidepressant Benefits: A Meta-Analysis of Data Submitted to the Food and Drug Administration , 2008, PLoS medicine.

[40]  S. L. Bridges Personalized medicine in rheumatoid arthritis: hopes and challenges. , 2007, Bulletin of the NYU hospital for joint diseases.

[41]  P. Lipsky,et al.  Benefit of an extract of Tripterygium Wilfordii Hook F in patients with rheumatoid arthritis: a double-blind, placebo-controlled study. , 2002, Arthritis and rheumatism.

[42]  Guowang Xu,et al.  Systems Biology Guided by Chinese Medicine Reveals New Markers for Sub-Typing Rheumatoid Arthritis Patients , 2009, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

[43]  F. Breedveld,et al.  Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis , 2005, Arthritis research & therapy.

[44]  N. Kohls,et al.  Spirituality, Suffering, and the Self , 2010 .

[45]  C. Lam,et al.  Safety and efficacy of Ganoderma lucidum (lingzhi) and San Miao San supplementation in patients with rheumatoid arthritis: a double-blind, randomized, placebo-controlled pilot trial. , 2007, Arthritis and rheumatism.

[46]  C. Wijbrandts,et al.  Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: assignment of a type I interferon signature in a subpopulation of patients , 2007, Annals of the rheumatic diseases.

[47]  R. Callard,et al.  Cytokines, chaos, and complexity. , 1999, Immunity.

[48]  J. Gaston,et al.  Cytokines in arthritis--the 'big numbers' move centre stage. , 2008, Rheumatology.

[49]  M. Liang,et al.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.

[50]  K. Wilber The Marriage of Sense and Soul: Integrating Science and Religion , 1998 .

[51]  T. Hankemeier,et al.  Metabolomics-based systems biology and personalized medicine: moving towards n = 1 clinical trials? , 2006, Pharmacogenomics.

[52]  Bridges Sl Personalized medicine in rheumatoid arthritis: hopes and challenges. , 2007 .

[53]  G. Lewith,et al.  The Impact of Positive and Negative Spiritual Experiences on Distress and the Moderating Role of Mindfulness , 2009 .

[54]  J. van der Greef,et al.  The art and practice of systems biology in medicine: mapping patterns of relationships. , 2007, Journal of proteome research.

[55]  P. V. van Riel,et al.  Is the disease course of rheumatoid arthritis becoming milder? Time trends since 1985 in an inception cohort of early rheumatoid arthritis. , 2005, Arthritis and rheumatism.

[56]  F. Capra The hidden connections : integrating the biological, cognitive, and social dimensions of life into a science of sustainability , 2002 .

[57]  Xuegong Zhang,et al.  Understanding ZHENG in traditional Chinese medicine in the context of neuro-endocrine-immune network. , 2007, IET systems biology.

[58]  David B Jackson Clinical and economic impact of the nonresponder phenomenon--implications for systems based discovery. , 2009, Drug discovery today.

[59]  Xin Chen,et al.  Chemokines and chemokine receptors as novel therapeutic targets in rheumatoid arthritis (RA): inhibitory effects of traditional Chinese medicinal components. , 2004, Cellular & molecular immunology.

[60]  J. van der Greef,et al.  Systems biology, connectivity and the future of medicine. , 2005, Systems biology.

[61]  A. Terzic,et al.  The Merck Manual, 18th Edition , 2007, Clinical pharmacology and therapeutics.

[62]  J. Greef,et al.  Rescuing drug discovery: in vivo systems pathology and systems pharmacology , 2005, Nature Reviews Drug Discovery.

[63]  Jan Schroën,et al.  Non-linear dynamics and Chinese medicine: an essay on research models, TCM, and recent changes in modern scientific philosophy , 2002 .

[64]  Wen-yue Jiang,et al.  Therapeutic wisdom in traditional Chinese medicine: a perspective from modern science. , 2005, Trends in pharmacological sciences.

[65]  Jeffrey Mervis Science and the stimulus. Science and the stimulus. , 2009, Science.

[66]  John P. Higgins,et al.  Nonlinear systems in medicine. , 2002, The Yale journal of biology and medicine.

[67]  R. Witkamp,et al.  Metabolomics in the context of systems biology: bridging traditional Chinese medicine and molecular pharmacology , 2005, Phytotherapy research : PTR.

[68]  L. Pearcy Diagnosis as narrative in ancient literature. , 1992, American journal of philology.